Kexing Pharmaceutical's first-half net profit attributable to parent reaches 134 million yuan, up 66.71% year-on-year

Earnings
โดย 央广财经·CN·Read original
Summary · why it matters

Kexing Pharmaceutical disclosed its semi-annual report, showing net profit attributable to shareholders of the listed company of 134 million yuan in the first half, up 66.71% year-on-year. During the reporting period, the company achieved operating revenue of 607 million yuan, down 13.33% year-on-year; basic earnings per share were 0.68 yuan.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews